These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 12434)

  • 1. Neurochemical changes following the administration of depleters of biogenic monoamines.
    Lane JD; Smith JE; Shea PA; McBride WJ
    Life Sci; 1976 Dec; 19(11):1663-7. PubMed ID: 12434
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution of putative neurotransmitters in the neocortex.
    Emson PC; Lindvall O
    Neuroscience; 1979; 4(1):1-30. PubMed ID: 32499
    [No Abstract]   [Full Text] [Related]  

  • 3. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.
    Azzaro AJ; Wenger GR; Craig CR; Stitzel RE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):558-68. PubMed ID: 4258979
    [No Abstract]   [Full Text] [Related]  

  • 4. A method for concurrent measurement of picomole quantities of acetylcholine, choline, dopamine, norepinephrine, serotonin, 5-hydroxytryptophan, 5-hydroxyindoleacetic acid, tryptophan, tyrosine, glycine, aspartate, glutamate, alanine, and gamma-aminobutyric acid in single tissue samples from different areas of rat central nervous system.
    Smith JE; Lane JD; Shea PA; McBride WJ; Aprison MH
    Anal Biochem; 1975 Mar; 64(1):149-69. PubMed ID: 237425
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines.
    Fulton SC; Healy MD
    Fed Proc; 1976 Dec; 35(14):2558-62. PubMed ID: 11134
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurochemistry of the vertebrate olfactory bulb.
    Halász N; Shepherd GM
    Neuroscience; 1983 Nov; 10(3):579-619. PubMed ID: 6196683
    [No Abstract]   [Full Text] [Related]  

  • 7. Some effects of dl-4-(2-hydroxy-3-isopropylaminopropoxy) indole (LB46) on brain monoamines and their precursors.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):79-93. PubMed ID: 5072194
    [No Abstract]   [Full Text] [Related]  

  • 8. Ultrastructural evidence for the localization of an indolealkylamine in supra-ependymal nerves from combined cytochemistry and pharmacology.
    Richards JG; Tranzer JP
    Experientia; 1974 Mar; 30(3):287-9. PubMed ID: 4274761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histochemical fluorescence detection of changes in central monoamine neurones provoked by drugs acting on the CNS.
    Fuxe K; Hökfelt T
    Triangle; 1971; 10(3):73-84. PubMed ID: 5138525
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetics of audiogenic seizures: II. Effects of pharmacological manipulation of brain serotonin, norepinephrine and gamma-aminobutyric acid.
    Schlesinger K; Boggan W; Freedman DX
    Life Sci; 1968 Apr; 7(7):437-47. PubMed ID: 4385105
    [No Abstract]   [Full Text] [Related]  

  • 11. The differential neurochemical bases of the behaviours elicited by serotonergic agents and by the combination of a monoamine oxidase inhibitor and L-DOPA.
    Deakin JF; Dashwood MR
    Neuropharmacology; 1981 Feb; 20(2):123-30. PubMed ID: 6451815
    [No Abstract]   [Full Text] [Related]  

  • 12. Social environment and brain biogenic amine metabolism in rats.
    Stolk JM; Conner RL; Barchas JD
    J Comp Physiol Psychol; 1974 Aug; 87(2):203-7. PubMed ID: 4279254
    [No Abstract]   [Full Text] [Related]  

  • 13. The relation between monoamines in brain and the anticonvulsant action of inhibition of carbonic anhydrase.
    Gray WD; Rauh CE
    J Pharmacol Exp Ther; 1971 Apr; 177(1):206-18. PubMed ID: 4254846
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of biogenic amines in amygdalar kindling. I. Local amygdalar afterdischarge.
    Wilkison DM; Halpern LM
    J Pharmacol Exp Ther; 1979 Oct; 211(1):151-8. PubMed ID: 158641
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of amino-oxyacetic acid, ethanolamine-O-sulphate and GABA on the contents of GABA and various amines in brain slices.
    Starr MS; Tanner T
    J Neurochem; 1975 Nov; 25(5):573-7. PubMed ID: 1194914
    [No Abstract]   [Full Text] [Related]  

  • 16. The possible role of brain monoamines in the acute toxicity of digitoxigenin.
    Buterbaugh GG; Spratt JL
    J Pharmacol Exp Ther; 1970 Oct; 175(1):121-30. PubMed ID: 4394300
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system.
    Andén NE
    Eur J Pharmacol; 1967 Jan; 1(1):1-5. PubMed ID: 6058896
    [No Abstract]   [Full Text] [Related]  

  • 18. Brain monoamines and the high pressure neurological syndrome.
    Koblin DD; Little HJ; Green AR; Daniels S; Smith EB; Paton WD
    Neuropharmacology; 1980 Nov; 19(11):1031-8. PubMed ID: 6449674
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.
    Butcher LL; Rhodes DL; Yuwiler A
    Eur J Pharmacol; 1972 May; 18(2):204-12. PubMed ID: 4537669
    [No Abstract]   [Full Text] [Related]  

  • 20. Central neurotransmitter effects of organotin compounds: trials, tribulations and observations.
    Hanin I; Krigman MR; Mailman RB
    Neurotoxicology; 1984; 5(2):267-77. PubMed ID: 6150454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.